Davide Leone & Partners Investment Company’s Array Biopharma Inc ARRY Stock Holding History

Davide Leone & Partners Investment Company’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,817,309	Closed	-$84.2M	–	17
2019 Q2	$84.2M	Buy	+1,817,309	New	+$51M	6.78%	6

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Davide Leone & Partners Investment Company's ARRY Position: Q3 2019 in Review

Davide Leone & Partners Investment Company sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 1,817,309 shares — an estimated $84.2M sold.

Davide Leone & Partners Investment Company first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $84.2M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Davide Leone & Partners Investment Company reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Davide Leone & Partners Investment Company sold 1,817,309 Array Biopharma Inc shares in Q3 2019, an estimated $84.2M.
Davide Leone & Partners Investment Company first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
Davide Leone & Partners Investment Company's Array Biopharma Inc position peaked at $84.2M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Davide Leone & Partners Investment Company's 13F filing for Q3 2019, filed 14 Nov 2019.